FibroBiologics director receives 30,803 stock options
FibroBiologics, Inc. director Niklas Victoria Ninon Olivia received a grant of 30,803 stock options to buy common stock at an exercise price of $0.7503 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
FibroBiologics, Inc. director Niklas Victoria Ninon Olivia received a grant of 30,803 stock options to buy common stock at an exercise price of $0.7503 per share. The options vest in full on the earlier of the first anniversary of grant or the next annual meeting and expire on June 22, 2036. Following this award, Olivia directly holds 30,803 options.
Insider Trade Summary
Grant/Award: 30,803 shares
Grant/Award
1 txn
Insider
Niklas Victoria Ninon Olivia
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 30,803 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 30,803 contracts (Direct)
Footnotes (1)
- F1. The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.
Key Figures
Options granted: 30,803 options
Exercise price: $0.7503 per share
Underlying shares: 30,803 shares
+2 more
5 metrics
Options granted
30,803 options
Stock Option (Right to Buy) granted to director
Exercise price
$0.7503 per share
Exercise price for underlying common stock
Underlying shares
30,803 shares
Common stock underlying the options
Post-transaction options held
30,803 options
Total options directly held after the grant
Expiration date
June 22, 2036
Option expiration for this award
Key Terms
Stock Option (Right to Buy), exercise price, Grant, award, or other acquisition, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy) linked to common stock"
exercise price financial
"conversion_or_exercise_price: 0.7503 per underlying common share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
vesting financial
"The options will vest in full upon the earlier of the first anniversary or next annual meeting"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting financial
"vest in full upon the earlier of the first anniversary or the date of the next annual meeting"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did FibroBiologics (FBLG) report for Niklas Olivia?
FibroBiologics reported that director Niklas Victoria Ninon Olivia received a grant of 30,803 stock options. These options give the right to buy common stock at an exercise price of $0.7503 per share, with vesting tied to time or the next annual meeting.
What are the key terms of the 30,803 stock options granted at FibroBiologics (FBLG)?
The grant covers 30,803 stock options on FibroBiologics common stock with an exercise price of $0.7503 per share. The options expire on June 22, 2036, providing a long-dated incentive tied to the company’s equity performance over time.
When do Niklas Olivia’s FibroBiologics (FBLG) options vest?
The options will vest in full on the earlier of two events: the first anniversary of the grant date or the date of FibroBiologics’ next annual meeting. This time-based vesting encourages continued board service through at least one full annual meeting cycle.
How many FibroBiologics (FBLG) options does Niklas Olivia hold after this grant?
After the reported transaction, Niklas Victoria Ninon Olivia directly holds 30,803 stock options. This total matches the size of the new award, indicating these are the options shown as outstanding for Olivia in this particular insider report.
Is the FibroBiologics (FBLG) transaction a purchase or a grant of options?
The transaction is a grant or award of stock options, not an open-market purchase. Classified under code “A,” it reflects compensation-related acquisition of derivative securities, giving Olivia the right to buy shares later at a fixed exercise price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
